ATOSSA THERAPEUTICS, INC. Balance Sheet
ATOS|5 years of annual SEC 10-K data (FY2012-FY2016)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
ATOSSA THERAPEUTICS, INC. had $6M in total assets and $9M in shareholders' equity as of FY2016.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8.5M | $8.5M | $6.3M | $0 | $0 |
| Accounts Receivable | - | - | $298.0K | $139.1K | $141.7K |
| Inventory | - | - | $39.8K | $0 | - |
| Current Assets | $4.3M | $4.3M | $9.1M | $7.4M | $2.0M |
| PP&E (Net) | $171.6K | $171.6K | $357.5K | $163.1K | $160.0K |
| Total Assets | $6.2M | $6.2M | $11.8M | $12.0M | $6.8M |
| Current Liabilities | $2.5M | $2.5M | $2.2M | $1.4M | $1.7M |
| Shareholders' Equity | $9.5M | $9.5M | $10.6M | $54.0K | $54.0K |